Mobile Cardiac Telemetry Systems Market Size, Share, Growth Analysis, By Application(Lead-based and Patch-based), By End user(Hospitals, Cardiac centers, and Others.), By Region - Industry Forecast 2024-2031

Mobile Cardiac Telemetry Systems Market size was valued at USD 830 million in 2022 and is poised to grow from USD 930.43 million in 2023 to USD 2320.21 million by 2031, at a CAGR of 12.1% during the forecast period (2024-2031).

Mobile cardiac telemetry (MCAT) is an innovative and real-time cardiac monitoring technology that offers convenient and reliable monitoring of patients with cardiac diseases. These advanced devices automatically detect and transmit ECG rhythms without requiring patient participation to a distant diagnostic monitoring laboratory, enabling continuous monitoring for up to 30 days. The growing mortality rates attributed to the high prevalence of cardiovascular disorders in the population are significant drivers for the expansion of the mobile cardiac telemetry (MCAT) market. Unhealthy lifestyle choices, including physical inactivity, obesity, and smoking, contribute to increased cardiac disorder incidences. Moreover, MCAT devices are increasingly being used to rapidly detect arrhythmogenic risks in COVID-19 patients during outpatient care, fueling market growth. Technological advancements and increased investments in the development and manufacturing of these devices, coupled with their widespread utilization for remote patient monitoring to reduce hospitalizations, are further propelling the mobile cardiac telemetry (MCAT) market. Additionally, factors such as global population growth, heightened awareness about diseases and treatments, high mortality rates, increased healthcare expenditure, and rising disposable incomes are positively impacting the demand for MCAT solutions.

US Mobile Cardiac Telemetry Systems Market is poised to grow at a sustainable CAGR for the next forecast year.